Skip to Content

Notice

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Exploratory Developmental Grant (R21) Program, RFA OH-02-001

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Exploratory Developmental Grant (R21) Program, RFA OH-02-001.

Times and Dates: 8 a.m.-8:30 a.m., February 19, 2002 (Open), 8:40 a.m.-5 p.m., February 19, 2002 (Closed), 8 a.m.-5 p.m., February 20, 2002 (Closed).

Place: Loews L'Enfant Plaza Hotel, 480 L'Enfant SW., Washington DC 20024.

Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Start Printed Page 5289Determination of the Deputy Director for Program Management, CDC, pursuant to Public Law 92-463.

Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to RFA OH-02-001.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Pervis Major, Ph.D., Scientific Review Administrator, National Institute for Occupational Safety and Health, CDC, 1095 Willowdale Road, M/S B228, telephone (304) 285-5979.

The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Dated: January 30, 2002.

Alvin Hall,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).

End Signature End Further Info End Preamble

[FR Doc. 02-2658 Filed 2-4-02; 8:45 am]

BILLING CODE 4163-19-P